COVID-19 and the intensive care unit: vaccines to the rescue
Kai Dallmeier, Geert Meyfroidt, Johan Neyts
Abstract
sponsorship: GM is funded by the Research Foundation, Flanders (FWO), as senior clinical investigator (1843118 N) and receives project research funding from the KU Leuven (C24/17/072), and the Belgian Federal Health Care Knowledge Center (KCE) (COV201003: Donated antibodies working against nCoV (DAWNPlasma)). The original work by JN is funded by the COVID-19 call of FWO (G0G4820N), the European Union's Horizon 2020 research and innovation program under grant agreements No 101003627 (SCORE project) and Bill & Melinda Gates Foundation (BGMF) under grant agreement INV-00636. (Research Foundation, Flanders (FWO)|1843118 N, KU Leuven|C24/17/072, Belgian Federal Health Care Knowledge Center (KCE)|COV201003, FWO|G0G4820N, European Union|101003627, Bill & Melinda Gates Foundation (BGMF)|INV-00636)